What Will be the Key Factors for Psoriasis Treatment Market Growth?

The increasing prevalence of psoriasis around the world is boosting the global psoriasis treatment market, says Fortune Business Insights in their recent report. The report is titled "Psoriasis Treatment Market: Global Market Analysis, Insights, and Forecasts, 2018 - 2025." According to the report, the market will reach US$ 37,634.2 Mn by 2026 from US$ 18,378.0 Mn in 2018, exhibiting a CAGR of 8.2% between 2018 and 2026.

Highlights of the Report:

o In-depth analysis of various insights, namely, Psoriasis Treatment Market trends, growth drivers, opportunities, and other related challenges.
o Comprehensive details of key market players, their core competencies, and Psoriasis Treatment Market share.
o The potency of suppliers and buyers to make better business decisions.
o Lists out the market size in terms of volume.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600

Key Players Operating in The Psoriasis Treatment Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o Merck & Co., Inc.,
o LEO Pharma A/S,
o Pfizer Inc.,
o Sun Pharmaceutical Industries Ltd,
o AbbVie Inc.,
o UCB S.A.,
o Amgen Inc.,
o Johnson & Johnson Services, Inc.,
o Eli Lilly and Company,
o others.

Rising Prevalence of Plaque Psoriasis to Increase Demand for Treatment, Boosting Market

One of the major factor boosting the global psoriasis treatment market is the increasing prevalence of the disease itself. The World Health Organization states that the prevalence of psoriasis is estimated to vary between 0.09% to 11.0% across all nations. This ultimately means that psoriasis is a serious problem. Psoriasis can occur to anyone irrespective of age but is usually reported to occur to aged people between 50 to 70 years. The rising geriatric population and their vulnerability towards diseases such as psoriatic arthritis are factor propelling growth of the market. These, coupled with the rising prevalence of plaque psoriasis, are likely to create growth opportunities for the market in the forecast period.

Request a Sample Copy of the Research Report:

North America to Continue Dominating Market with Rapid Adoption of Biological Therapy

Fortune Business Insights foresees the global psoriasis market to witness dominance of North America followed by Europe. As per the National Psoriasis Foundation, there are about 8 million people in America living with psoriasis. Owing to its quick rate of biological therapy adoption, and rise in investments on research and development for clinical trials, North America is likely to continue dominating the global market for psoriasis in the forecast period as well.

On the other side, the emerging markets in the Middle East and Africa, Latin America, and Asia Pacific are expected to offer lucrative growth opportunities because of large patient pool, the improving healthcare infrastructure and medical facilities; increasing awareness, and with rising investments for development of new therapeutics for psoriasis.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/psoriasis-treatment-market-100600

Detailed Table of Content:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Psoriasis and Psoriatic Arthritis for Key Countries/Region
4.2. Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
4.3. Pipeline Analysis for Key Companies
4.4. Regulatory Framework by Key Countries
4.5. Global Reimbursement Scenario
5. Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast - By Drug Class
5.2.1. TNF Inhibitors
5.2.2. Interleukins
5.2.3. Others
5.3. Market Analysis, Insights and Forecast - By Type
5.3.1. Plaque Psoriasis
5.3.2. Psoriatic Arthritis
5.3.3. Others
5.4. Market Analysis, Insights and Forecast - By Route of Administration
5.4.1. Oral
5.4.2. Parenteral
5.4.3. Topical
5.5. Market Analysis, Insights and Forecast - By Distribution Channel
5.5.1. Hospital Pharmacies
5.5.2. Retail Pharmacies
5.5.3. Online pharmacies
5.6. Market Analysis, Insights and Forecast - By Region
5.6.1. North America
5.6.2. Europe
5.6.3. Asia pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
6. North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis - By Drug Class
6.2.1. TNF Inhibitors
6.2.2. Interleukins
6.2.3. Others
6.3. Market Analysis - By Type
6.3.1. Plaque Psoriasis
6.3.2. Psoriatic Arthritis
6.3.3. Others
6.4. Market Analysis - By Route of Administration
6.4.1. Oral
6.4.2. Parenteral
6.4.3. Topical
6.5. Market Analysis - By Distribution Channel
6.5.1. Hospital Pharmacies
6.5.2. Retail Pharmacies
6.5.3. Online pharmacies
6.6. Market Analysis - By Country/Sub-region
6.6.1. U.S.
6.6.2. Canada
7. Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis - By Drug Class
7.2.1. TNF Inhibitors
7.2.2. Interleukins
7.2.3. Others
7.3. Market Analysis - By Type
7.3.1. Plaque Psoriasis
7.3.2. Psoriatic Arthritis
7.3.3. Others
7.4. Market Analysis - By Route of Administration
7.4.1. Oral
7.4.2. Parenteral
7.4.3. Topical
7.5. Market Analysis - By Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2. Retail Pharmacies
7.5.3. Online pharmacies
7.6. Market Analysis - By Country/Sub-region
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. Australia
7.6.5. Southeast Asia
7.6.6. Rest of Asia Pacific
Continued...

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.